Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein

Proteomics
Jonathan K WilliamsJean Baum

Abstract

Several intrinsically disordered proteins have been implicated in the process of amyloid fibril formation in neurodegenerative disease, and developing approaches to inhibit the aggregation of these intrinsically disordered proteins is critical for establishing effective therapies against disease progression. The aggregation pathway of the intrinsically disordered protein alpha-synuclein, which is implicated in several neurodegenerative diseases known as synucleinopathies, has been extensively characterized. Less attention has been leveraged on beta-synuclein, a homologous intrinsically disordered protein that co-localizes with alpha-synuclein and is known to delay alpha-synuclein fibril formation. In this review, we focus on beta-synuclein and the molecular-level interactions between alpha-synuclein and beta-synuclein that underlie the delay of fibril formation. We highlight studies that begin to define alpha-synuclein and beta-synuclein interactions at the monomer, oligomer, and surface levels, and suggest that beta-synuclein plays a role in regulation of inhibition at many different stages of alpha-synuclein aggregation.

References

May 23, 1994·FEBS Letters·R JakesM Goedert
Nov 5, 1999·Journal of Molecular Biology·P E Wright, H J Dyson
Apr 5, 2001·Journal of Molecular Biology·D EliezerG Browne
Jan 29, 2003·The Journal of Biological Chemistry·Heather SnyderBenjamin Wolozin
Mar 27, 2004·The Journal of Biological Chemistry·Jochen KluckenPamela J McLean
Sep 15, 2004·Neurology·H OhtakeA R La Spada
Oct 7, 2004·Journal of the American Society for Mass Spectrometry·Summer L BernsteinJay R Winkler
Nov 24, 2004·Chemistry & Biology·Jie LiAnthony L Fink
Dec 14, 2004·The Journal of Biological Chemistry·Heather SnyderBenjamin Wolozin
Dec 24, 2004·The Journal of Biological Chemistry·Tobias S UlmerRobert L Nussbaum
Mar 2, 2005·Nature Reviews. Molecular Cell Biology·H Jane Dyson, Peter E Wright
Jun 22, 2005·Biochemistry·Ghiam YaminAnthony L Fink
Apr 7, 2006·Protein Science : a Publication of the Protein Society·Yoon-Hui Sung, David Eliezer
Jun 8, 2006·Annual Review of Biochemistry·Fabrizio Chiti, Christopher M Dobson
Nov 8, 2006·Protein Science : a Publication of the Protein Society·Joseph A MarshJulie D Forman-Kay
Aug 8, 2007·Journal of Molecular Biology·Yoon-Hui Sung, David Eliezer
Jan 25, 2008·BMC Bioinformatics·Yang Zhang
Mar 5, 2008·Journal of the American Chemical Society·Chun TangG Marius Clore
Jul 7, 2009·Journal of Molecular Biology·Kuen-Phon WuJean Baum
Dec 17, 2009·Science·Tuomas P J KnowlesChristopher M Dobson
Jun 29, 2010·Methods in Enzymology·Allan Chris M FerreonAshok A Deniz
Sep 10, 2011·Proteins·Ilona B BruinsmaMarcel M Verbeek
Apr 14, 2012·Reviews in the Neurosciences·Steven P BraithwaiteM Maral Mouradian
Aug 28, 2012·Journal of Molecular Biology·Vanessa C Ducas, Elizabeth Rhoades
Mar 29, 2013·Annals of Neurology·Grit TaschenbergerSebastian Kügler
May 15, 2013·Nucleic Acids Research·Hamish McWilliamRodrigo Lopez
Aug 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Rahul K Das, Rohit V Pappu
Sep 21, 2013·Neuron·Jacob T BendorRobert H Edwards
Dec 10, 2013·Journal of the American Chemical Society·Paolo ArosioSara Linse
Jan 7, 2014·Frontiers in Bioscience (Scholar Edition)·Janice M Beitz
May 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Alexander K BuellChristopher M Dobson
May 24, 2014·Nature Reviews. Molecular Cell Biology·Tuomas P J KnowlesChristopher M Dobson

❮ Previous
Next ❯

Citations

Jun 14, 2019·Immunology and Cell Biology·Sarah A Richman, Christopher A Hunter
Mar 1, 2019·Biomolecules·Wenning Wang, Dongdong Wang
Jan 20, 2022·ACS Chemical Neuroscience·Sapir Lan-Mark, Yifat Miller
Feb 6, 2022·Movement Disorders : Official Journal of the Movement Disorder Society·Lorenzo BarbaLucilla Parnetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.